<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0370712</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3660</journal-id>
<journal-id journal-id-type="nlm-ta">Exp Neurol</journal-id>
<journal-id journal-id-type="iso-abbrev">Exp. Neurol.</journal-id>
<journal-title-group>
<journal-title>Experimental neurology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0014-4886</issn>
<issn pub-type="epub">1090-2430</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30268766</article-id>
<article-id pub-id-type="pmc">6263818</article-id>
<article-id pub-id-type="doi">10.1016/j.expneurol.2018.09.019</article-id>
<article-id pub-id-type="manuscript">NIHMS1508915</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Self-reinforcing effects of mTOR hyperactive neurons on dendritic
growth</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Arafa</surname>
<given-names>Salwa R.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>LaSarge</surname>
<given-names>Candi L.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pun</surname>
<given-names>Raymund Y.K.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khademi</surname>
<given-names>Shadi</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Danzer</surname>
<given-names>Steve C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Anesthesia, Cincinnati Children’s
Hospital Medical Center, Cincinnati, OH, 45229</aff>
<aff id="A2"><label>2</label>Department of Drug Development, James L Winkle College of
Pharmacy, University of Cincinnati, OH, 45267</aff>
<aff id="A3"><label>3</label>Departments of Anesthesia and Pediatrics, University of
Cincinnati, Cincinnati, OH, 45267</aff>
<author-notes>
<corresp id="CR1">Corresponding author: Dr. Steve C. Danzer, 3333 Burnet Avenue, ML
2001, Cincinnati, Ohio 45229-3039, (513) 636-4526 (phone), (513) 636-7337 (fax),
<email>steve.danzer@cchmc.org</email></corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P46">Conflict of interest: The authors have nothing to report</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>10</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>28</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2020</year>
</pub-date>
<volume>311</volume>
<fpage>125</fpage>
<lpage>134</lpage>
<!--elocation-id from pubmed: 10.1016/j.expneurol.2018.09.019-->
<abstract id="ABS1">
<p id="P1">Loss of the mTOR pathway negative regulator PTEN from hippocampal dentate
granule cells leads to neuronal hypertrophy, increased dendritic branching and
aberrant basal dendrite formation in animal models. Similar changes are evident
in humans with mTOR pathway mutations. These genetic conditions are associated
with autism, cognitive dysfunction and epilepsy. Interestingly, humans with mTOR
pathway mutations often present with mosaic disruptions of gene function,
producing lesions that range from focal cortical dysplasia to
hemimegalanecephaly. Whether mTOR-mediated neuronal dysmorphogenesis is impacted
by the number of affected cells, however, is not known. mTOR mutations can
produce secondary comorbidities, including brain hypertrophy and seizures, which
could exacerbate dysmorphogenesis among mutant cells. To determine whether the
percentage or “load” of PTEN knockout granule cells impacts the
morphological development of these same cells, we generated two groups of PTEN
knockout mice. In the first, PTEN deletion rates were held constant, at about
5%, and knockout cell growth over time was assessed. Knockout cells exhibited
significant dendritic growth between 7 and 18 weeks, demonstrating that aberrant
dendritic growth continues even after the cells reach maturity. In the second
group of mice, PTEN was deleted from 2–37% of granule cells to determine
whether deletion rate was a factor in driving this continued growth.
Multivariate analysis revealed that both age and knockout cell load contributed
to knockout cell dendritic growth. Although the mechanism remains to be
determined, these findings demonstrate that large numbers of mutant neurons can
produce self-reinforcing effects on their own growth.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>